Загрузка...
The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus
Dengue virus (DENV) is listed as one of the NIAID Category A priority pathogens. Dengue disease is endemic in most tropical countries, with an estimated 2.5 billion people living in areas at risk of DENV infection. Due to the lack of vaccines and antiviral drugs, it is now a huge public health burde...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2802053/ https://ncbi.nlm.nih.gov/pubmed/20057980 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|